Igf-independent regulation of breast cancer growth by IGF binding proteins (original) (raw)
References
Salmon WD, Daughaday WH: A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med 49:825–836, 1957 Google Scholar
Daughaday WH, Hall K, Raben MS, Salmon WD, Van den Brande JLV, Van Wyk JJ: Somatomedin: Proposed designation for sulphation factor. Nature 235:107, 1972 Google Scholar
Daughaday WH, Rotwein P: Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endocrine Rev 10:68–91, 1989 Google Scholar
Rosenfeld RG, Lamson GL, Pham H, Oh Y, Conover C, DeLeon DD, Donovan SM, Ocrant I, Giudice LC: Insulin-like growth factor-binding proteins. Rec Progr Horm Res 46:99–159, 1991 Google Scholar
Baxter RC, Martin JL: Binding proteins for the insulin-like growth factors: structure, regulation and function. Progr Growth Factor Res 1:49–68, 1989 Google Scholar
Jones JL, Clemmons DR: Insulin-like growth factors and their binding proteins: biological actions. Endocrine Rev 16:3–34, 1995 Google Scholar
Oh Y, Muller HL, Neely EK, Lamson G, Rosenfeld RG: New concepts in insulin-like growth factor receptor physiology. Growth Regul 3:113–123, 1993 Google Scholar
Werner H, Woloschak M, Stannard B, Shen-Orr Z, Roberts CT Jr, LeRoith D: The insulin-like growth factor receptor, molecular biology, heterogencity and regulation. In: LeRoith D (ed) Insulin-like Growth Factors: Molecular and Cellular Aspects. CRC Press, Boca Raton FL, 1991, pp 17–47 Google Scholar
Lowe L: Biological actions of the insulin-like growth factors. In: LeRoith D (ed) Insulin-like Growth Factors: Molecular and Cellular Aspects. CRC Press, Boca Raton FL, 1991, pp 49–85 Google Scholar
Kelley KM, Oh Y, Gargosky SE, Gucev Z, Matsumoto T, Hwa V, Ng L, Simpson D, Rosenfeld RG: Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochem Cell Biol 28:619–637, 1995 Google Scholar
Jones JI, Clemmons DR: Insulin-like growth factors and their binding proteins: biological actions. Endocrine Rev 16:3–34, 1995 Google Scholar
Swisshelm K, Ryan K, Tsuchiya K, Sager R: Enhanced expression of an insulin growth factor-like binding protein (mac25) in senescent human mammary epithelial cells and induced with retinoic acid. Proc Natl Acad of Sci USA 92:4472–4476, 1995 Google Scholar
Oh Y, Nagalla SN, Yamanaka Y, Kim H, Wilson L, Rosenfeld RG: Identification and characterization of insulin-like growth factor binding protein (IGFBP)-7: recombinant human mac25 protein specifically binds IGF-I and-II. J Biol Chem 271:30322–30325, 1996 Google Scholar
Osborne CK, Coronado EB, Kitten LJ, Artcaga CI, Fuqua SAW, Ramasharma K, Marshall M, Li CH: Insulin-like growth factor II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor. Mol Endocrinol 3:1701–1709, 1989 Google Scholar
De Leon DD, Wilson DM, Powers M, Rosenfeld RG: Effects of insulin-like growth factors (IGFs) and IGF receptor antibodies on the proliferation of human breast cancer cells. Growth Factors 6:327–336, 1992 Google Scholar
Furlanetto RW, DiCarlo JN: Somatomedin C receptors and growth effects in human breast cancer cells maintained in long-term culture. Cancer Res 44:2122–2128, 1984 Google Scholar
Huff KK, Kaufman D, Gabbay KH, Spencer EM, Lippman ME, Dickson RB: Human breast cancer cells secrete an insulin-like growth factor-1-related polypeptide. Cancer Res 46:4613–4619, 1986 Google Scholar
Westley B, May FEB: IGFs and control of cell proliferation in human breast and other cancers. Reviews on Endocrine-Related Cancer 39:29–34, 1991 Google Scholar
Baxter RC, Maitland JE, Raisur RL, Reddel R, Sutherland RL: High molecular weight somatomedin-C (IGF-I) from T47D human mammary carcinoma cells: immunoreactivity and bioactivity. In: Spencer EM (ed) Insulin-like Growth Factors/Somatomedins. De Gruyter, Berlin, 1983, pp 615–618 Google Scholar
Cullen KJ, Smith HS, Hill S, Rosen N, Lippman ME, Yee D: Growth factor mRNA expression by human breast fibroblasts from benign and malignant lesions. Cancer Res 51:4978–4985, 1991 Google Scholar
Paik S: Expression of IGF-I and IGF-II mRNA in breast tissue. Breast Cancer Res Treat 22:31–38, 1992 Google Scholar
Cullen KJ, Yee D, Sly WS, Perduc J, Hampton B, Lippman ME, Rosen N: Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res 50:48–53, 1990 Google Scholar
Bonneterre J, Peyrat JP, Beuscart R, Demaille A: Prognostic significance of insulin-like growth factor receptors in human breast cancer. Cancer Res 50:6931–6935, 1990 Google Scholar
Peyrat JP, Bonneterre J: The type 1 IGF receptor in human breast diseases. Breast Cancer Res Treat 22:59–67, 1992 Google Scholar
De Leon DD, Bakker B, Wilson DM, Hintz RL, Rosenfeld RG: Demonstration of insulin-like growth factor (IGF-I and-II) receptors and binding proteins in human breast cancer cell lines. Biochem Biophys Res Commun 152:398–405, 1988 Google Scholar
Papa V, Hartmann KKP, Rosenthal SM, Maddux BA, Siiteri PK, Goldfine ID: Progestins induce down regulation of insulin-like growth factor I (IGF-I) receptors in human breast cancer cells: potential autocrine role of IGF-II. Mol Endocrinol 5:709–717, 1991 Google Scholar
Colletti RB, Roberts JD, Devlin JT, Copeland KC: Effect of tamoxifen on plasma insulin-like growth factor I in patients with breast cancer. Cancer Res 49:1882–1884, 1989 Google Scholar
Reed MJ, Christodoulides A, Koistinen R, Seppala M, Teale JD, Ghilchik MW: The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxyandrostenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-1 in women with advanced breast cancer. Int J Cancer 52:208–212, 1992 Google Scholar
Pollak MN, Huynh HT, Lefebvre SP: Tamoxifen reduces serum insulin-like growth factor I (IGF-I). Breast Cancer Res Treat 22:91–100, 1992 Google Scholar
Pollak MN: Effects of adjuvant tamoxifen therapy on growth hormone and insulin-like growth factor I (IGF-I) physiology. In: Salmon SE (ed) Adjuvant Therapy of Cancer VII. Lippincott, 1993, pp 43–53
Figueroa JA, Jackson JG, McGuire WL, Krywicki RF, Yee D: Expression of insulin-like growth factor binding proteins in human breast cancer correlates with estrogen receptor status. J Cell Biochem 52:196–205, 1993 Google Scholar
Rosenfeld RG: Somatomedin action and tissue growth-factor receptors. In: Robbins RJ, Mclmcd S (eds) Acromegaly. Plenum Press, New York, 1987, pp 45–53 Google Scholar
Oh Y, Muller HL, Neely EK, Lamson G, Rosenfeld RG: New concepts in insulin-like growth factor receptor physiology. Growth Regul 3:113–123, 1993 Google Scholar
Hintz RL, Liu F: Demonstration of specific plasma protein binding sites for somatomedin. J Clin Endocrinol Metab 45:988–982, 1977 Google Scholar
Baxter RC, Martin JL, Tayler MI, Howden MEH: Growth hormone dependent insulin like growth factor (IGF) binding protein from human plasma differs from other human IGF binding proteins. Biochem Biophys Res Commun 139:1256–1259, 1986 Google Scholar
Guler HP, Zapf J, Schmid C, Froesch ER: Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinol (Copenh) 121:753–758, 1989 Google Scholar
Baxter RC, Martin JL: Binding proteins for the insulin-like growth factors: structure, regulation, and function. Prog Growth Factor Res 1:49–56, 1989 Google Scholar
Martin JL, Coverley JA, Pattison ST, Baxter RC: Insulin-like growth factor-binding protein-3 production by MCF-7 breast cancer cells: Stimulation by retinoic acid and cyclic adenosine monophosphate and differential effects of estradiol. Endocrinology 136:1219–1226, 1995 Google Scholar
Paik S: Expression of IGF-I and IGF-II mRNA in breast tissue. Breast Cancer Res Treat 22:31–38, 1992 Google Scholar
Pratt SE, Pollak MN: Estrogen and antiestrogen modulation of MCF-7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor-binding proteins in conditioned media. Cancer Res 53:5193–5198, 1993 Google Scholar
Capony F, Rougeot C, Montcourrier P, Cavailles V, Salazar G, Rochefort H: Increased secretion, altered processing and glycosylation of pro-cathepsin D in human mammary cancer cells. Cancer Res 49:3904–3909, 1989 Google Scholar
Conover CA, De Leon DD: Acid-activated insulin-like growth factor binding protein 3 proteolysis in normal and transformed cells. Role of cathepsin D. J Biol Chem 269:7076–7080, 1994 Google Scholar
Yu H, Diamandis EP, Sutherland DJA: Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age. Clinical Biochem 27:75–79, 1994 Google Scholar
Cohen P, Graves HCB, Peehl DM, Kamarei M, Giudice LC, Rosenfeld RG: Prostate specific antigen (PSA) is an IGF binding protein-3 (IGFBP-3) protease found in seminal plasma. J Clin Endocrinol Metab 75:1046–1053, 1993 Google Scholar
Schmitt M, Goretzki L, Janicke F, Calvete J, Eulitz M, Kobayashi H, Chucholowski N, Graeff H: Biological and clinical relevance of the urokinase-type plasminogen activator in breast cancer. Biomedica Biochimica Acta 50:731–741, 1991 Google Scholar
Lee DY, Park SK, Yorgin PD, Cohen P, Oh Y, Rosenfeld RG: Alteration of insulin-like growth factor-binding proteins (IGFBPs) and IGFBP-3 protease activity in serum and urine from acute and chronic renal failure. J Clin Endocrinol Metab 79:1376–1382, 1994. Google Scholar
Cohen P, Peehl DM, Lamson G, Rosenfeld RG: Insulin-like growth factors (IGFs), IGF receptors and IGF binding proteins in primary cultures of prostate epithelial cells. J Clin Endocrinol Metab 73:401–407, 1991 Google Scholar
Lalou C, Lassarre C, Binoux M: A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin. Endocrinology 137:3206–3212, 1996 Google Scholar
Pratt SE, Pollak MN: Estrogen and antiestrogen modulation of MCF-7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor-binding proteins in conditioned media. Cancer Res 53:5193–5198, 1993 Google Scholar
Pratt SE, Pollak MN: Insulin-like growth factor binding protein 3 (IGFBP-3) inhibits estrogen-stimulated breast cancer cell proliferation. Biochem Biophys Res Commun 198:292–297, 1994 Google Scholar
Oh Y, Muller HL, Lamson G, Rosenfeld RG: Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. J Biol Chem 268:14964–14971, 1993 Google Scholar
Oh Y, Muller HL, Pham HM, Rosenfeld RG: Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. J Biol Chem 268:26045–26048, 1993 Google Scholar
Oh Y, Müller HL, Ng L, Rosenfeld RG: TGF-β-induced cell growth inhibition in human breast cancer cells is mediated through IGFBP-3 action. J Biol Chem 270:13589–13592, 1995 Google Scholar
Gucev ZS, Kelley KM, Rosenfeld RG, Oh Y: Insulin-like growth factor binding protein-3 (IGFBP-3) mediates retinoic acid (RA)-and transforming growth factor-β2 (TGF-β2)-induced growth inhibition in human breast cancer cells. Cancer Res 56:1545–1550, 1996 Google Scholar
Oh Y, Muller HL, Pham HM, Lamson G, Rosenfeld RG: Non-receptor mediated, post-transcriptional regulation of insulin-like growth factor binding protein (IGFBP)-3 in Hs578T human breast cancer cells. Endocrinology 131:3123–3125, 1992 Google Scholar
Kraus MH, Yuasa Y, Aaronson SA: A position 12-activated H-ras oncogene in all Hs578T mammary carcinosarcoma cells but not normal mammary cells of the same patient. Biochem 81:5384–5388, 1984 Google Scholar
Kozma S, Boggard M, Buser K, Saurer S, Bos J, Groner B, Hynes N: The human c-Kirsten ras gene is activated by a novel mutation in codon 13 in the breast carcinorma cell line MDA-MD-231. Nucleic Acids Res 15:5963–5970, 1987 Google Scholar
Davidson NE, Gelmann EP, Lippman ME, Dickson RB: Epidermal growth factor receptor gene expression in estrogen receptor positive and negative human breast cancer cell lines. Mol Endocrinol 1:216–223, 1987 Google Scholar
Yamanaka Y, Fowlkes JL, Rosenfeld RG, Oh Y: Characterization of insulin-like growth factor binding protein-3 (IGFBP-3) binding to human breast cancer cells. J Biol Chem (submitted), 1997
Knabbe C, Lippman ME, Wakefield LM, Flanders KC, Kasid A, Derynck R, Dickson RB: Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48:417–428, 1987 Google Scholar
Fontana JA, Burrows-Mczu A, Clemmons DR, LeRoith D: Retinoid modulation of insulin-like growth factor-binding proteins and inhibition of breast carcinoma proliferation. Endocrinology 128:1115–1122, 1990 Google Scholar
Martin JL, Ballesteros M, Baxter RC: Insulin-like growth factor-I (IGF-I) and transforming growth factor-beta 1 release IGF-binding protein-3 from human fibroblasts by different mechanisms. Endocrinology crinology 131:1703–1710, 1992 Google Scholar
San Roman GA, Magoffin DA: Insulin-like growth factor binding proteins in ovarian follicles from women with polycystic ovarian disease: cellular source and levels in follicular fluid. J Clin Endocrinol Metab 75:1010–1016, 1992 Google Scholar
Huynli H, Yang X, Pollak M: Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells. J Biol Chem 271:1016–1021, 1996 Google Scholar
Valentinis B, Bhala A, DeAngelis T, Baserga R, Cohen P: The human insulin-like growth factor (IGF) binding protein-3 inhibits cell growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol Endocrinol 9:361–367, 1995 Google Scholar
Delbe J, Blat C, Desauty G, Harel L: Presence of IDF45 (mIGFBP-3) binding sites on chick embryo fibroblasts. Biochem Biophys Res Commun 179:495–501, 1991 Google Scholar
Andreatta-Van Leyen S, Hembree JR, Eckert RL: Regulation of insulin-like growth factor binding protein 3 levels by epidermal growth factor and retinoic acid in cervical epithelial cells. J Cell Physiol 160:265–274, 1994 Google Scholar
Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR, Kley N: Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377:646–649, 1995 Google Scholar
Wilson EM, Oh Y, Rosenfeld RG: Generation and characterization of an IGFBP-7 antibody: Identification of 31-kDa IGFBP-7 in human biological fluids and Hs578T human breast cancer conditioned media. J Clin Endocrinol Metab 82:1301–1303, 1997 Google Scholar